The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Significant Portion of Psoriatic Arthritis Patients Don't Receive Any Treatment
Despite the pervasiveness of psoriasis and psoriatic arthritis, undertreatment and nontreatment of even the most severe forms of those systemic rheumatic diseases are widespread in the United States.
Osteoarthritis: Has Oversimplification Led to Confusion?
August 15th 2013One reason no good solution yet exists for osteoarthritis may be that rheumatology has been viewing many disease processes as a single entity. In an editorial, four rheumatologists offer a new disease model that they hope will rationalize future clinical research.
Link Between Herbal Medicines for Arthritis and Liver Cancer Explained
August 12th 2013Researchers have nailed the reason why several herbal nostrums for arthritis and gout cause malignancy, including hepatocellular cancer previously attributed to hepatitis C. Also in the non-rheumatology journals this week: News about comorbidities of psoriasis and antibody profiles for morphea.
Inadequate Vitamin D May Increase Risk of Certain Rheumatic Diseases
While substantial evidence already shows several genetic and environmental elements factor into immune-mediated rheumatic disease susceptibility, a recent review of hospital admissions data suggests vitamin D deficiency can single-handedly elevate a patient's risk of developing certain chronic conditions within that group of disorders.
Though physicians are already aware that rheumatoid arthritis (RA) and ankylosing spondylitis (AS) cause inflammation in joints, tendons, and surrounding muscle tissues, the effects of those chronic autoimmune disorders on stiffness, strength, and function of the patellar tendon have not yet been determined.
Diagnosing and Managing Gout – 10 International Recommendations
August 1st 2013An international panel of rheumatologists issues new recommendations for the diagnosis and management of gout -- hoping to improve often uneven and suboptimal patient care that exists despite numerous care guidelines and new therapies.
Lubricin: New Promise for Joint-Preserving Therapy
July 31st 2013Evidence from animal and human studies supports efforts to use the natural lubricant proteoglycan 4 (lubricin) to protect joints threatened by injury or disease, primarily osteoarthritis. The only thing wanted now is clinical proof of the concept. Gregory Jay MD PhD reviews the history and the potential of this new strategy.
Inflammatory Cell Counts in Gout Tissues Closely Linked to Hypertension Presence
A pair of researchers based in Texas has gained valuable insight into the correlation between individual cell type in the tissues of gout patients and comorbidity factors of the chronic inflammatory autoimmune disorder.
Though recent reviews were unable to provide evidence of efficacy for several complementary treatments for rheumatoid arthritis (RA), a group of researchers decided to clinically evaluate the effectiveness of static electric field therapy by high voltage alternating current (EF-HVAC) in the chronic inflammatory autoimmune disorder.
PML and Rituximab: What Rheumatologists Should Know
July 26th 2013Progressive multifocal leukoencephalopathy (PML) is a rare but potentially fatal adverse effect of biologic therapy for rheumatologic disorders. Here, a specialist on the topic from Cleveland Clinic offers a brief review of the risks and realities.
Transforaminal Morphine Effective for Lumbar Radicular Pain, But Not Superior to Tramadol Injection
Transforaminal epidural steroid injections (TFEI) have become a more common approach to relieving chronic lumbar radicular pain, but until now, no published clinical reports had directly compared morphine with tramadol for that indication.